A patients' rights group yesterday delivered about 10,000 signatures from patients and their relatives protesting against the Hospital Authority's planned standard drug list. The Central Drug Formulary, which is under consultation until April 30, lists 1,273 drugs that patients would receive at a cost of $10. Other drugs, including 26 cancer medicines, would be available at that price subject to means-testing. Patients' Rights Association spokesman Tim Pang Hung-cheong, who delivered the signatures at an hour-long meeting with authority executives, said he left disappointed. 'The authority said that perhaps after reviewing the list, some of the medicines would be put back into the Central Drug Formulary. They also said if the Samaritan Fund was unable to attract more private funding, it might try to put more drugs back under the safety net,' Mr Pang said. The Samaritan Fund is a charity that helps pay for drugs that patients cannot afford. The authority said a Formulary Review Committee would be set up once the list was implemented. Mr Pang's group countered that a patient's representative should be a member of the committee. They also reiterated that the means test for the Samaritan Fund should be reviewed. 'It is very stringent now,' Mr Pang said. 'Many families whose income exceeds the median income are not wealthy enough to afford drugs such as Glivec.' Under the plan, the means test applies to Glivec for leukaemia, Paclitaxel for breast cancer, Interferon for hepatitis and Somatropin for hormone treatment.